Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Arrowhead Pharmaceuticals Inc., 3 years.
Arrowhead Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −2,799 | $66.63 | $186,497 |
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −5,281 | $67.97 | $358,950 |
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,960 | $68.39 | $134,044 |
| Dec 16, 2025 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,819 | — | — |
| Dec 18, 2024 | Arrowhead Pharmaceuticals Inc. | Grant or award | +16,733 | $22.99 | $384,692 |
| Dec 16, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −8,994 | $21.91 | $197,059 |
| May 2, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,799 | $23.31 | $41,935 |
| Jan 11, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −3,620 | $37.87 | $137,089 |
| Jan 11, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,100 | $38.84 | $42,724 |
| Dec 15, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +14,987 | $25.41 | $380,820 |
| Sep 28, 2023 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,550 | $26.33 | $40,812 |
| Jan 10, 2023 | Arrowhead Pharmaceuticals Inc. | Sold back to the company | −1,764 | — | — |
| Jan 10, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,867 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.